Evidence map›Paper›PMID 38137481›Full record

ReviewBiomedicines2023

The Role of Irisin throughout Women's Life Span.

Federica Barbagallo, Rossella Cannarella, Vincenzo Garofalo, Marta Marino, Sandro La Vignera, Rosita A Condorelli, Lara Tiranini, Rossella E Nappi, Aldo E Calogero

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Menstrual Dysfunction in Adolescent Female Athletes.Sports (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Federica BarbagalloDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.
Rossella CannarellaDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0003-4599-8487
Vincenzo GarofaloDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0002-4193-9730
Marta MarinoDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0002-0981-1956
Sandro La VigneraDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0002-7113-2372
Rosita A CondorelliDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0002-5217-9343
Lara TiraniniDepartment of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Rossella E NappiDepartment of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0003-1713-6396
Aldo E CalogeroDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0001-6950-335X
University of Catania · ITUniversity of Pavia · ITCleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since its discovery, much attention has been drawn to irisin's potential role in metabolic and reproductive diseases. This narrative review summarizes and updates the possible role played by this fascinating molecule in different physiological (puberty and menopause) and pathological (polycystic ovary syndrome (PCOS), functional hypothalamic amenorrhea (FHA), endometriosis, and gestational diabetes) conditions that can affect women throughout their entire lives. Irisin appears to be an important factor for the hypothalamic-pituitary-gonadal axis activation, and appears to play a role in the timing of puberty onset. Serum irisin levels have been proposed as a biomarker for predicting the future development of gestational diabetes (GDM). Its role in PCOS is still controversial, although an "irisin resistance" mechanism has been hypothesized. In addition to its impact on metabolism, irisin also appears to influence bone health. Irisin levels are inversely correlated with the prevalence of fractures in postmenopausal women. Similar mechanisms have also been postulated in young women with FHA. In clinical settings, further controlled, prospective and randomized clinical trials are needed to investigate the casual relationship between irisin levels and the conditions described and, in turn, to establish the role of irisin as a prognostic/diagnostic biomarker or a therapeutic target.

Indexed as

bone healthfunctional hypothalamic amenorrhea (FHA)gestational diabetes (GDM)HPG axisirisinmenopausemetabolismpolycystic ovary syndrome (PCOS)reproduction

Identifiers

PMID38137481
PMCPMC10741019
OpenAlexW4389547451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.